Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Annals of the Rheumatic Diseases
|
February 2, 2012
Can flare be predicted in DMARD treated RA patients in remission, and is it important? A cohort study
Benazir Saleem, Andrew K Brown, Mark Quinn, et al.
Rheumatology (Oxford, England)
|
November 13, 2010
Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
Sarah L Westlake, Alexandra N Colebatch, Janis Baird, et al.
Annals of the Rheumatic Diseases
|
January 19, 2011
Should imaging be a component of rheumatoid arthritis remission criteria? A comparison between traditional and modified composite remission scores and imaging assessments
Benazir Saleem, Andrew K Brown, Helen Keen, et al.
Arthritis and Rheumatism
|
July 1, 2009
Disease remission state in patients treated with the combination of tumor necrosis factor blockade and methotrexate or with disease-modifying antirheumatic drugs: A clinical and imaging comparative study
Benazir Saleem, Andrew K Brown, Helen Keen, et al.
Arthritis and Rheumatism
|
January 16, 2003
Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis
Philip G Conaghan, Philip O'Connor, Dennis McGonagle, et al.
Annals of the Rheumatic Diseases
|
April 28, 2010
Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?
Benazir Saleem, Helen Keen, Vincent Goeb, et al.
Rheumatology (Oxford, England)
|
April 30, 2009
Contemporary treatment principles for early rheumatoid arthritis: a consensus statement
Patrick D W Kiely, Andrew K Brown, Christopher J Edwards, et al.
Clinical Epigenetics
|
December 21, 2023
A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide
Prodromos Chatzikyriakou, Dimitria Brempou, Mark Quinn, et al.
Endocrine-Related Cancer
|
March 10, 2025
Clinical, genetic, radiological characteristics and management of mediastinal paragangliomas: a literature review and case series
Mark Quinn, Yasmine Kemkem, Gemma White, et al.
Arthritis and Rheumatism
|
September 30, 2008
Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis
Victoria Bejarano, Mark Quinn, Philip G Conaghan, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Annals of the Rheumatic Diseases
|
February 2, 2012
Can flare be predicted in DMARD treated RA patients in remission, and is it important? A cohort study
Benazir Saleem, Andrew K Brown, Mark Quinn, et al.
Rheumatology (Oxford, England)
|
November 13, 2010
Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
Sarah L Westlake, Alexandra N Colebatch, Janis Baird, et al.
Annals of the Rheumatic Diseases
|
January 19, 2011
Should imaging be a component of rheumatoid arthritis remission criteria? A comparison between traditional and modified composite remission scores and imaging assessments
Benazir Saleem, Andrew K Brown, Helen Keen, et al.
Arthritis and Rheumatism
|
July 1, 2009
Disease remission state in patients treated with the combination of tumor necrosis factor blockade and methotrexate or with disease-modifying antirheumatic drugs: A clinical and imaging comparative study
Benazir Saleem, Andrew K Brown, Helen Keen, et al.
Arthritis and Rheumatism
|
January 16, 2003
Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis
Philip G Conaghan, Philip O'Connor, Dennis McGonagle, et al.
Annals of the Rheumatic Diseases
|
April 28, 2010
Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?
Benazir Saleem, Helen Keen, Vincent Goeb, et al.
Rheumatology (Oxford, England)
|
April 30, 2009
Contemporary treatment principles for early rheumatoid arthritis: a consensus statement
Patrick D W Kiely, Andrew K Brown, Christopher J Edwards, et al.
Clinical Epigenetics
|
December 21, 2023
A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide
Prodromos Chatzikyriakou, Dimitria Brempou, Mark Quinn, et al.
Endocrine-Related Cancer
|
March 10, 2025
Clinical, genetic, radiological characteristics and management of mediastinal paragangliomas: a literature review and case series
Mark Quinn, Yasmine Kemkem, Gemma White, et al.
Arthritis and Rheumatism
|
September 30, 2008
Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis
Victoria Bejarano, Mark Quinn, Philip G Conaghan, et al.
Page
of 4